Piramal CDMO begins solid oral dose production in the US

PPS has entered into an agreement with G&W Laboratories to acquire its solid oral dosage drug product manufacturing facility located in Pennsylvania, US

picture of

Breaking News

LGM Pharma acquires CDMO unit of Nexgen Pharma

The combined firm has all the capabilities to accelerate and optimise the new product pathway, from early R&D and ...

Piramal Pharma Solutions announces integrated development programme with Bolt Biotherapeutics

PPS is handling production of Bolt’s Boltbody Immune Stimulating Antibody Conjugate (ISAC), BDC-1001, currently in a ...

CMIC Group establishes biopharma CDMO in Japan

Single-use facility in Shizuoka, Japan has been established to provide process development and GMP manufacturing of ...

Reducing time-to-market with innovative approaches to analytical services

The way in which drug developers approach analytical chemistry can be crucial in terms of driving efficiencies in ...

GRAM opens fill-finish US facility

Grand River Aseptic Manufacturing has discussed details of the cGMP parenteral drug manufacturing, analytical testing, ...

ViralClear partners with CDMO on potential COVID-19 treatment Merimepodib

ViralClear Pharmaceuticals has partnered with Albany Molecular Research Inc (AMRI) on the manufacture of Merimepodib ...

Cleanroom Conference and Manufacturing Chemist Live events set to go ahead

The co-located events will go ahead in October with new safety measures in place, after being postponed from their ...

Vetter expands development service with new Austrian site

Global CDMO has invested in additional capacity to meet growing demand for complex fill and finish solutions

New line for contract filling orders

Contract manufacturer SternMaid offers a diversity of equipment for filling products into different packs for the ...

Zenith on the buzzwords for pharma 2020

Joe Haugh, Zenith Technologies CEO, describes 2019 as a real watershed year, with topics such as Industry 4.0, ...

Delivering certainty in uncertain times

Contract manufacturing organisations (CMOs) in the pharmaceutical sector operate at the sharp end of an industry in ...

Integrated solutions offer fast-track development for biopharmaceuticals

At the heart of any successful medicine launch is a robust manufacturing process that will reliably make the product in ...

Renibus chooses Cascade Chemistry for COVID-19 contract manufacturing

Cascade has been selected to produce the clincal trial API supplies for investigational therapy entering a Phase 2 ...

PCI and Experic announce strategic drug supply chain collaboration

Complementary technologies and capabilities add value and drive growth for both companies